文献速递慢性静脉疾病

慢性静脉疾病与主要不良心血管事件风险的关联

Association of chronic venous disease with major adverse cardiovascular events.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-09-08

在澳大利亚北昆士兰两家医院前瞻性纳入774例慢性静脉疾病(CVD)患者,按CEAP分级评估严重程度并随访中位3.09年。校正传统危险因素后,重症CVD患者发生主要不良心血管事件(MACE)的风险高于轻症患者。

要点

  • C6期CVD患者MACE风险约为C2期的3倍。
  • 重症CVD(CEAP C5–C6)较轻症(C2–C4)MACE风险升高。
  • 关联独立于传统心血管危险因素,提示需关注重症CVD患者心血管风险。

核心结论

  • 重症慢性静脉疾病患者较轻症患者MACE风险升高,且独立于传统危险因素。
  • C6期CVD患者较C2期MACE风险约高三倍。
  • 超额风险的机制尚需进一步研究明确。

研究设计与样本

  • 前瞻性队列研究,从澳大利亚北昆士兰两家医院血管专科门诊招募CVD患者。
  • 共纳入774例,随访中位3.09年(四分位距1.09–8.14年)。
  • CVD严重程度由血管专科医生按CEAP分类判定。
  • MACE定义为心肌梗死、卒中或心血管死亡,来源于门诊随访及关联病历。
  • 采用Kaplan-Meier和Cox比例风险分析。

主要发现

  • C6期CVD(n=69)较C2期(n=326)MACE风险升高,校正后HR 3.03(95%CI 1.02–9.03,P=.046)。
  • 重症CVD较轻症CVD的MACE校正后HR 2.37(95%CI 1.12–5.04,P=.024)。

关键数值与推荐

  • CVD严重程度按CEAP分类判定。
  • 亚组分析将CEAP C5–C6定义为重症CVD,CEAP C2–C4定义为轻症CVD。
  • MACE定义为心肌梗死、卒中或心血管死亡。

临床怎么用

  • 对CEAP C5–C6等重症CVD患者,除静脉专科处理外应评估并管理心血管风险。
  • 随访中可将MACE作为重症CVD患者的关注结局之一。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the present study was to examine whether severe chronic venous disease (CVD) is associated with a greater risk of major adverse cardiovascular events (MACE) compared with mild CVD. METHODS: Participants with CVD were prospectively recruited from outpatient vascular departments at two hospitals in North Queensland, Australia. CVD severity was ascertained by vascular specialists using the CEAP (clinical, etiologic, anatomic, pathophysiologic) classification. MACE, defined as myocardial infarction, stroke, or cardiovascular death, were identified from the outpatient follow-up and linked medical records. Kaplan-Meier and Cox proportional hazard analyses were used to examine the association of CVD severity with the occurrence of MACE. A subanalysis was performed in which participants with CEAP C5 and C6 (severe CVD) were compared with those with CEAP C2 to C4 (mild CVD). RESULTS: A total of 774 participants were included and followed up for a median of 3.09 years (interquartile range, 1.09-8.14 years). The participants with C6 CVD (n = 69) had a threefold greater risk of MACE (hazard ratio, 3.03; 95% confidence interval, 1.02-9.03; P = .046) compared with those with C2 CVD (n = 326) after adjusting for other risk factors. Participants with severe CVD had an increased risk of MACE compared with those with mild CVD (adjusted hazard ratio, 2.37; 95% confidence interval, 1.12-5.04; P = .024). CONCLUSIONS: Individuals with severe CVD have an increased risk of MACE compared with those with mild CVD, independently of traditional risk factors. Further research is required to clarify the cause of the excess risk.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Singh TP, Velu RB, Quigley F, et al. Association of chronic venous disease with major adverse cardiovascular events. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34506962. doi:10.1016/j.jvsv.2021.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。